AKTIS SOMA
http://sbfhealthcare.com/cancer.html ![[WBL]](../../images/archive-org-icon-very-small.png){kind=icon}
Cancer treatment trials were conducted at the Institute of Aerospace Medicine, Indian Air Force, Bangalore, from July 2004 to July 2006 under the supervision of Wg Cdr (Dr) VG Vasishta (Retd). In this trial, all the patients had completed standard treatment modalities such as chemotherapy, surgery and radiotherapy; they were on palliative care and had volunteered for the Cancer treatment. All the patients were exposed to Quantum Magnetic Resonance Therapy™ or SPMF Therapy™, daily for 1 hour for 28 consecutive days and were assessed using the Karnofsky (Quality of life) Performance Scale scores before and after the exposure.
The statistical analysis of the results revealed a highly significant correlation between SPMF Therapy™ exposure and Karnofsky (Quality of life) score improvement and also survival period. 60% of the patients, who were given a few weeks to a few months of survival by their oncologists, survived for longer periods and even resumed their routine work.
AKTIS is een soortgelijk apparaat als de CYTOTRON van QURESS
In ieder geval is bij beide het Institute of Aerospace Medicine, Indian Air Force, Bangalore,
--from July 2004 to July 2006 under the supervision of Wg Cdr (Dr) VG Vasishta (Retd),--
in actie geweest.
De Cytotron heeft het over de RFQMR en de AKTIS noemt dat QMR en/of SPFM.
Net als de Cytotron een kwestie van grootspraak.